| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Research Immunology/Bone Marrow Transplantation, Children's Hospital Los Angeles and University of Southern California, School of Medicine, Department of Pediatrics and School of Dentistry, Department of Craniofacial Molecular Biology, Los Angeles, California, USA
Key Words. Differentiation • Retroviral-mediated transduction • Marrow stroma immune deficient mice • Stem cells • Xenotransplantation
Dr. Jan A. Nolta, Division of Research Immunology/Bone Marrow Transplantation, Children's Hospital Los Angeles and University of Southern California, School of Medicine, Department of Pediatrics and School of Dentistry, Department of Craniofacial Molecular Biology, 4650 Sunset Boulevard, Mailstop No. 62, Los Angeles, CA 90027, USA.
Human hematopoiesis can be supported in beige/nude/ XID (bnx) mice by coinjection of human bone marrow stromal cells engineered to secrete human interleukin 3 (HuIL-3). The major limitation is a total absence of human B cell development in the mice, which could be due to supraphysiological levels of HuIL-3 in the circulation. In an effort to obtain human B lymphoid, as well as T lymphoid and myeloid cell development in the mice, CD34+ cells were coinjected with human marrow stromal cells engineered to secrete human IL-2, IL-7, stem cell factor or FLT3 ligand, ± IL-3. No single factor other than IL-3 supported sustained human hematopoiesis in the mice, although cytokines were expressed for four to six months post-transplantation. Production of both HuIL-3 and IL-7 in the mice supported extrathymic development of human T lymphocytes, but no B cells, myeloid cells, or clonogenic progenitors were detected. Human B cells were not produced from CD34+ cells in the bnx mice under any condition tested. Another limitation to the bnx/Hu system is a lack of maturation of human red blood cells, although BFU-E are maintained. Stromal cells secreting human erythropoietin and IL-3 were cotransplanted into mice with HuCD34+ cells and an increase in hematocrit from 40%-45% to 80%-85% resulted, with production of human and murine red blood cells. Unfortunately, all mice (n = 9) suffered strokes, displayed paralysis and died within three weeks. The bnx/Hu cotransplantation model provides an interesting system in which to study human hematopoietic cell differentiation under the influence of various cytokines.
This article has been cited by other articles:
|
|
 |
|
  I. Rosova, M. Dao, B. Capoccia, D. Link, and J. A. Nolta Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells Stem Cells, August 1, 2008; 26(8): 2173 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Meyerrose, M. Roberts, K. K. Ohlemiller, C. A. Vogler, L. Wirthlin, J. A. Nolta, and M. S. Sands Lentiviral-Transduced Human Mesenchymal Stem Cells Persistently Express Therapeutic Levels of Enzyme in a Xenotransplantation Model of Human Disease Stem Cells, July 1, 2008; 26(7): 1713 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Meyerrose, D. A. De Ugarte, A. A. Hofling, P. E. Herrbrich, T. D. Cordonnier, L. D. Shultz, J. C. Eagon, L. Wirthlin, M. S. Sands, M. A. Hedrick, et al. In Vivo Distribution of Human Adipose-Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models Stem Cells, January 1, 2007; 25(1): 220 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Legrand, K. Weijer, and H. Spits Experimental Models to Study Development and Function of the Human Immune System In Vivo J. Immunol., February 15, 2006; 176(4): 2053 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nolta Improved method to bridge mouse and man Blood, January 15, 2004; 103(2): 370 - 371. [Full Text] [PDF]
|
|
|
|
|
|
H. Hiramatsu, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, K. Katamura, and T. Nakahata Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/{gamma}cnull mice model Blood, August 1, 2003; 102(3): 873 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, S. Ge, G. McNamara, Q.-L. Hao, G. M. Crooks, and J. A. Nolta Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells Blood, May 15, 2003; 101(10): 4201 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nitsche, I. Junghahn, S. Thulke, J. Aumann, A. Radonic, I. Fichtner, and W. Siegert Interleukin-3 Promotes Proliferation and Differentiation of Human Hematopoietic Stem Cells but Reduces Their Repopulation Potential in NOD/SCID Mice Stem Cells, March 1, 2003; 21(2): 236 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dao, J. Arevalo, and J. A. Nolta Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution Blood, January 1, 2003; 101(1): 112 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dao, J. Hwa, and J. A. Nolta Molecular mechanism of transforming growth factor beta -mediated cell-cycle modulation in primary human CD34+ progenitors Blood, January 15, 2002; 99(2): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Tsark, M. A. Dao, X. Wang, K. Weinberg, and J. A. Nolta IL-7 Enhances the Responsiveness of Human T Cells That Develop in the Bone Marrow of Athymic Mice J. Immunol., January 1, 2001; 166(1): 170 - 181. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
